Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
R. Paul Gray currently holds 7,500 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Paul Gray has been a net seller of UTHR stock. They have purchased $0 and sold $11.8M worth of shares.
R. Paul Gray's most recent insider trade was on Nov 1, 2013, when they sold 7,500 shares at $90.34 per share.
R. Paul Gray serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 74 insider transactions totaling $11.8M over their tenure at the company.
R. Paul Gray holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
R. Paul Gray has shown a selling trading pattern, with $0 in total purchases and $11.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by R. Paul Gray was on May 3, 2011, when they sold $4.5M worth of UTHR shares. This transaction involved 66,000 shares at $67.94 per share.
R. Paul Gray currently owns 7,500 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of R. Paul Gray's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Paul Gray has 74 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for R. Paul Gray and 40,000+ other insiders.